U-Blot® Research Grade TuparstobartCat. No. WA3712Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade TuparstobartCat. No. WA3712
U-Blot® Research Grade TulisokibartCat. No. WA3711
U-Blot® Research Grade TulinerceptCat. No. WA3710
U-Blot® Research Grade TucotuzumabCat. No. WA3709
U-Blot® Research Grade trovostobartCat. No. WA3708
U-Blot® Research Grade TrosunilimabCat. No. WA3707
U-Blot® Research Grade trosovavilp alfaCat. No. WA3706
U-Blot® Research Grade TrontinemabCat. No. WA3705
U-Blot® Research Grade TrinbelimabCat. No. WA3704
U-Blot® Research Grade trevotamigCat. No. WA3703
U-Blot® Research Grade TrevogrumabCat. No. WA3702
U-Blot® Research Grade TremelimumabCat. No. WA3701